Ajax Harwood Clinic

MTHFR and methylation testing: should I be tested?

Last reviewed 2026-09-23Content veef68cf90660

Reference tool — not medical advice. Clinician judgement always required.

Elevated homocysteine / folate and B12 status

Defined testing criteria

Also called: high homocysteine, hyperhomocysteinemia, homocysteine level

Homocysteine sometimes comes back elevated on an ND-ordered panel, often marketed as a cardiovascular or 'methylation' risk marker, or is checked after a patient learns they carry an MTHFR gene variant, which they've been told raises homocysteine.

Raises suspicion

• A low or borderline B12 or folate level, or an easily identified cause such as reduced kidney function
• Recurrent unprovoked blood clots at a young age, especially with a family history of early clotting, which may point to a separate, rare inherited condition (classic homocystinuria) rather than the mild elevations discussed here
• Developmental delay, intellectual disability, lens dislocation, or a marfanoid body build, which also suggest classic homocystinuria and need genetics referral

Does not raise suspicion

• A mildly elevated homocysteine found on a general wellness or cardiovascular-risk panel, with no B12, folate, or kidney problem and no personal or family history suggestive of classic homocystinuria
• An MTHFR gene result on its own, with or without a homocysteine level

Red flags

• Features suggestive of classic homocystinuria (lens dislocation, marfanoid build, developmental delay, unprovoked clotting at a young age) need genetics referral

Who to test

Elevated homocysteine found incidentally, with no obvious cause: Vitamin B12 (cobalamin) (Situation-specific), Folate (serum and RBC folate) (Situation-specific), Kidney function (creatinine/eGFR, BUN, urine albumin-to-creatinine ratio) (Situation-specific)Check for treatable causes first: B12 or folate deficiency, or reduced kidney function. MTHFR genotype does not need to be checked (see the MTHFR section of this page).
Borderline B12 result with symptoms that don't clearly fit: Homocysteine (Situation-specific), Vitamin B12 (cobalamin) (Situation-specific)Homocysteine can help clarify true B12 status, though it is less specific than methylmalonic acid.

More likely instead

• An elevated homocysteine found on a screening or wellness panel is most often explained by B12 or folate insufficiency, reduced kidney function, or ordinary lab variability, not by a distinct disease needing its own treatment
• Lowering homocysteine with B vitamins has not been shown to reduce heart attacks or death, so treating the number itself is not the goal, unlike managing standard cardiovascular risk factors such as blood pressure, cholesterol, smoking, and activity

Counselling script

“An elevated homocysteine on its own isn't something I treat as a target, because lowering it with B vitamins hasn't been shown to prevent heart attacks or reduce death. What's more useful is figuring out why it's high, usually a B12 or folate level, or kidney function, so I'd rather check those directly than focus on the homocysteine number itself.”

Chart snippet (OSCAR-safe plain text)

Concern discussed, not tested

Concern re: elevated homocysteine discussed.
Discriminating features: low B12 or folate, reduced kidney function, unprovoked blood clotting at a young age, features of classic homocystinuria; absent.
Assessment: homocysteine elevation, if present, not treated as an independent cardiovascular target.
Plan: homocysteine testing not ordered.
Ref: Cochrane homocysteine-lowering review 2017.
Patient given info page: https://mthfr.ajaxharwoodclinic.com/patient
Revisit if: unprovoked blood clotting at a young age, or features suggestive of classic homocystinuria, develop.

Testing ordered

Ordered: B12, folate, and kidney function. Indication: elevated homocysteine on prior testing, to identify a treatable cause.
Plan: homocysteine-lowering with B vitamins is not used to reduce cardiovascular risk; MTHFR genotype testing not ordered.
Ref: Cochrane homocysteine-lowering review 2017; British Society for Haematology cobalamin and folate guideline 2014.

Revisit if

• Unprovoked blood clotting at a young age or a relevant family history
• Features suggestive of classic homocystinuria: lens dislocation, marfanoid build, developmental delay
• New B12 or folate deficiency, or new kidney disease

References

1. Cochrane. Homocysteine-lowering interventions for preventing cardiovascular events (2017)Homocysteine-lowering supplementation with B vitamins did not reduce myocardial infarction or all-cause mortality across 15 RCTs
2. British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014)— older guidelinePlasma homocysteine may be a helpful second-line test for clarifying uncertain B12 status, though less specific than methylmalonic acid
3. Canadian Hematology Society / Choosing Wisely Canada. Choosing Wisely Canada Labs Recommendations - Full List (2022)Don't order thrombophilia testing in women with early pregnancy loss, a context in which homocysteine/MTHFR testing is often proposed but not supported

Evidence notes

Tag A: homocysteine is a real, measurable lab value with defined, if narrow, validated uses, so A fits better than B or C, though this page is unusual in being anchored on a lab marker rather than a named disease; flagging this as a structural choice for the reviewer to confirm, not a clinical borderline call. This record is the proposed real-condition anchor for the mthfr subdomain, per docs/open-questions.md item 4's proposal that mthfr. anchor on elevated homocysteine and folate/B12 status, with the MTHFR/methylation label hosted inside it; this is a proposal pending Dr. Yu's sign-off, not a settled decision. Classic homocystinuria (CBS deficiency) is mentioned to explain why very high homocysteine with specific features differs from the mild elevations discussed here; this is standard genetics teaching not independently sourced this session and was out of scope for this batch's research budget. Reviewer: tag A is borderline because this is a lab finding, not a named disease. Listed for Dr. Yu under open question 4 (mthfr. structure). Resolved 2026-09-23: Dr. Yu approved the mthfr. structure with this anchor, and kept the tag as drafted (decisions 4 and 10).

Popular labels: what they mean

MTHFR mutation / methylation problems

Not a recognized medical diagnosis

Also called: MTHFR mutation, methylation problems, undermethylation, overmethylation, need methylfolate, MTHFR gene variant, MTHFR C677T, MTHFR A1298C

Patients usually learn about an MTHFR gene variant from a direct-to-consumer test such as 23andMe, or from an ND, and are often told it explains fatigue, anxiety, migraines, infertility, miscarriage, or trouble 'detoxing,' with methylfolate recommended instead of folic acid or a standard multivitamin.

Does not raise suspicion

• Fatigue, anxiety, brain fog, migraines, or trouble conceiving in someone who has an MTHFR variant on a DNA test: these symptoms are common and real, but they are not explained by the MTHFR result itself
• A single miscarriage or difficulty conceiving attributed to MTHFR, without a separate, recognized fertility or thrombophilia workup finding

Red flags

• None specific to an MTHFR result itself. If there is a genuine concern about unprovoked blood clotting, recurrent pregnancy loss, or elevated homocysteine, that concern is addressed directly rather than through MTHFR testing (see the elevated homocysteine section of this page)

Who to test

Anyone with, or considering, an MTHFR genotype resultMTHFR genotype testing has no validated clinical use and is not recommended. If there is a genuine concern about homocysteine, B12, or folate status, or a thrombophilia indication, test those directly instead (see this page's elevated homocysteine section and the b12 page).

More likely instead

• Fatigue and brain fog: sleep, mood, or thyroid problems (see insomnia, depression, and thyroid tools)
• Migraines: a primary headache disorder
• Recurrent pregnancy loss or infertility: a standard fertility and thrombophilia work-up that does not include MTHFR
• Unprovoked blood clotting: standard thrombophilia testing, which does not include MTHFR

Counselling script

“MTHFR gene testing isn't something I'd order or act on, because research hasn't shown that this variant reliably predicts blood clots, pregnancy loss, or the fatigue and brain fog it's sometimes blamed for, and genetics guidelines recommend against testing for it. If you're specifically worried about your homocysteine, B12, or folate, we can check those directly instead, and if you already have an MTHFR result from a DNA test, we don't need to act on it without a separate reason.”

Chart snippet (OSCAR-safe plain text)

Concern discussed, not tested

Concern re: MTHFR mutation / methylation problems discussed. Patient reports a direct-to-consumer or ND-ordered MTHFR result.
Discriminating features: unprovoked blood clotting at a young age, recurrent pregnancy loss, features of classic homocystinuria; absent.
Assessment: MTHFR genotype does not reliably predict these outcomes and is not a recognized diagnosis on its own. Symptoms discussed and validated.
Plan: MTHFR testing not ordered or acted on.
Ref: American College of Medical Genetics and Genomics 2013.
Patient given info page: https://mthfr.ajaxharwoodclinic.com/patient#mthfr
Revisit if: a specific, treatable concern such as elevated homocysteine, B12 or folate deficiency, or a genuine thrombophilia indication is identified; that concern is tested directly.

Testing ordered

Ordered: homocysteine, B12, and folate, to address the underlying concern directly. MTHFR genotype not ordered, consistent with genetics guidance against testing for it.
Ref: American College of Medical Genetics and Genomics 2013; Cochrane homocysteine-lowering review 2017.

Revisit if

• Elevated homocysteine, B12 deficiency, or folate deficiency is identified: managed directly
• A genuine thrombophilia indication, such as an unprovoked blood clot or a qualifying family or pregnancy-loss history, arises: tested with validated thrombophilia testing, not MTHFR

References

1. American College of Medical Genetics and Genomics (ACMG). ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing (2013)MTHFR testing has minimal clinical utility and should not be ordered as part of a routine thrombophilia evaluation
2. Cochrane. Homocysteine-lowering interventions for preventing cardiovascular events (2017)No reduction in cardiovascular events from homocysteine-lowering interventions compared with placebo, undercutting the pathway MTHFR testing is meant to flag
3. Canadian Hematology Society / Choosing Wisely Canada. Choosing Wisely Canada Labs Recommendations - Full List (2022)Don't order thrombophilia testing in women with early pregnancy loss, a context in which MTHFR is often proposed but not supported

Evidence notes

Tag C: MTHFR/'methylation problems' is not a recognized medical diagnosis; the professional consensus (ACMG) explicitly advises against ordering or acting on the test, so this tag is not borderline. Structural note: host is set to the literal string 'mthfr' (the subdomain slug) rather than the anchor condition's own id 'Elevated homocysteine / folate and B12 status', per this batch's explicit instruction and docs/open-questions.md item 4's proposal that mthfr. anchor on elevated homocysteine/folate/B12 status with the MTHFR label hosted inside it. This differs slightly from a strict reading of schema.md ('host: the condition id ... whose page this lives inside'), which would suggest host: 'Elevated homocysteine / folate and B12 status' instead. Both the anchor structure and this host-value convention are proposals pending Dr. Yu's sign-off, not settled decisions, and the reviewer should confirm which id the C-tag record's host should actually carry before Phase 2. Resolved 2026-09-23: Dr. Yu approved the anchor structure (decision 4); host = the page's subdomain slug, per docs/schema.md.

General clinical reference for Ajax Harwood Clinic. Not medical advice, and not a substitute for individualized clinical assessment.